Cooling particle accelerators: What you need to know

When it comes to cooling particle accelerators, advanced liquid cooling systems don’t have to extend the design cycle or the budget, according to Laird. Greg Ducharme, Laird Particle accelerators, such as linear accelerator (LINAC) and cyclotron systems, increase the kinetic energy of particles for use in a variety of applications, ranging from scientific studies on particle

These 10 medtech companies care a lot about research

Among the world’s largest medtech companies, these 10 spent the largest portion of their budgets on research and development. So what have they produced? Every year, Medical Design & Outsourcing pulls financial regulatory filings and reaches out to major, companies in some cases to create a list of the 100 largest medical device companies in

Pages: 1 2 3 4 5 6 7 8 9 10 11

Philips announces innovations around imaging, pediatrics and more

Philips today announced new imaging products and services, as well as a 10-year, strategic partnership with Children’s Hospital & Medical Center of Omaha, Neb. The news is latest of a slew of announcements out of Philips during the Radiological Society of North America (RSNA) conference that is taking place this week in Chicago. Philips yesterday announced three new

Philips is expanding its radiology offerings: Here’s how

Philips today announced three new products and services related to its radiology offerings, including 3D printed models, a new CT scanner and an extension of a partnership with Banner Health. On the 3D printing front, agreements with industry leaders 3D Systems and Stratasys will enable Philips customers through Philips’s IntelliSpace Portal 10 to have a seamless

These 7 antique medical devices will make you shudder

It’s a good thing we live in the times of modern medicine. Historically, medical devices have been scary and unorthodox – and sometimes amounted to downright quackery. Surprisingly, a lot of these devices were thought to be useful in their era, long before the U.S. FDA started preapproving devices (which wasn’t until the 1970s). You

Pages: 1 2 3 4 5 6 7 8

Infab introduces Revolution lead aprons

Infab Corp. is touting its new Revolution lead and lead-free aprons with Kiarmor, Infab’s proprietary bi-layer radiation protection core material. Kiarmor is the only core material in the world currently certified to IEC61331-1:2014 standards and the only lead-free core material to pass the stringent DIN standards, Infab noted in a news release yesterday. Lightweight Revolution aprons provide unrivaled

This LED-based device predicts radiation skin damage

Researchers at UC Irvine’s Beckman Laser Institute are developing imaging to predict the skin damage that breast cancer patients will experience from radiation treatment, The Optical Society reported today. “We use visible and near-infrared light at very low power and project it onto the breast. We are trying to characterize the skin damage during radiation

Genetically engineered T-cells treat leukemia in babies

Researchers in London have successfully treated leukemia in two babies, in what they are touting as the world’s first treatment of cancer using genetically engineered immune cells from donors. Doctors treated two British infants, 11 and 16 months old, using Cellectis’s CAR T-cell product, UCART19, which is an allogeneic CAR T-cell product candidate for the

How nanodiscs could eliminate cancer cells

University of Michigan researchers have successfully developed a cancer vaccine that fights to eliminate colon and melanoma cancer cells and prevent tumor growth in mice. Nanodiscs loaded with tumor neoantigens deliver a customized therapeutic vaccine targeting cancer mutations. The neoantigens are unique mutations found in tumor cells, and the technology of the nanodiscs recognizes the

Three new studies demonstrate value of MammaPrint and BluePrint in individualizing treatment for breast cancer patients

Agendia, a world leader in personalized medicine and molecular cancer diagnostics, highlights new data on its gold-standard MammaPrint 70-Gene Breast Cancer Recurrence Assay and BluePrint 80-Gene Molecular Subtyping Assay, from three studies presented at the San Antonio Breast Cancer Symposium last week. Researchers from the University of South Florida Morsani College of Medicine reported long-term

ZDi Solutions receives FDA approval for patented proton therapy and conventional radiation therapy positioning devices

ZDi Solutions announced that it has received approval from the U.S. Food and Drug Administration for its Z-System patient positioning devices for proton therapy and conventional radiation therapy. The company announced in late September that it has begun marketing both in the U.S. and internationally. The system is comprised of the Z-Box, Z-Square and Z-Tilt.

UVA scientists create novel imaging technique with potential for medical diagnostics

A unique new imaging method, called “polarized nuclear imaging”—combining powerful aspects of both magnetic resonance imaging and gamma-ray imaging and developed by two physicists in the University of Virginia’s departments of Physics and Radiology—has potential for new types of high-resolution medical diagnostics as well as industrial and physics research applications. “This method makes possible a

Robot in the cath lab takes surgeons out of radiation’s way

A recently devised robotic system aimed at cath-lab interventions reduces the radiation exposure of surgeons by 95% while still allowing precise sub-millimeter measurement and 1 mm advancement accuracy. Physicians who have used the equipment say that by optimizing stent selection and positioning, the CorPath Vascular Robotic System lets them position the right stent in the

ScandiDos unveils Delta4 Synthesis at ASTRO Annual Meeting in Boston

ScandiDos, a company in Quality Assurance (QA) and dosimetry for modern radiation therapy, unveils the world’s first and only Non-Extrapolated Radiation Accuracy Measurement system, Delta4 Synthesis and Express Measure, at the ASTRO Annual Meeting on September 25 to 27 at the Boston Convention and Exhibition Center. Delta4 Synthesis combines Delta4 Phantom+ and Delta4 Discover, FDA 510(k)

Colorectal cancer patients show response to resin microspheres

New data was presented by Prof. Dr. Volker Heinemann in an oral abstract session at the European Society of Medical Oncology’s 18th World Congress on Gastrointestinal Cancer. The data suggest that patients with liver-dominant mCRC, treated first-line with the combination of mFOLFOX6 and SIR-Spheres Y-90 resin microspheres experienced a profound response to treatment in the